• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 AXIUM HELIX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 AXIUM HELIX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number QC-7-30-HELIX
Device Problems Therapy Delivered to Incorrect Body Area (1508); Stretched (1601); Use of Device Problem (1670)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 11/21/2021
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information reporting that a coil was stretched and the wire was cut and left in the patient's body.That patient was undergoing a coil embolization procedure to treat a saccular c6 segment aneurysm.The aneurysm max diameter was 7mm and the neck diameter was 5mm.Vessel tortuosity was normal.It was reported that during the procedure, the qc-7-30-helix coil was second coil to be used.There was no friction or other difficulty observed during testing or delivery of the coil.The surgeon performed several adjustments such as pushing and pulling the coil after which the coil was stretched but not detached.The surgeon withdrew the spring wire and the catheter together but the distal end of the coil remained connected with the coil implanted in the aneurysm and could not be withdrawn completely from the patient's body.At the femoral artery access, the surgeon cut the stretched spring wire shore and part of the wire stayed in the patient's body.It was noted the length of the spring wire in the body extended approximately from the aneurysm to the femoral artery puncture site.Subsequently, the surgeon implanted a solitaire stent to prevent the wire from floating excessively in the patient's vessel.It was unknown if the patient experienced any symptoms or additional complications associated with the event at the time the report was received.
 
Event Description
Additional information was received.The patient did not experience any symptoms or complications associated with the wired remaining in the vessel.Part of the spring coil and part of the spring wire was cut and remained in the vessel.The cause of the coil stretch necessitating the cut of the wire determined was because they were unable to withdraw from the body, only cut off the part to stay in the body.An attempt was made to detach the coil.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIUM HELIX
Type of Device
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key12936478
MDR Text Key285263846
Report Number2029214-2021-01565
Device Sequence Number1
Product Code KRD
UDI-Device Identifier00847536029644
UDI-Public00847536029644
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K081465
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/22/2024
Device Model NumberQC-7-30-HELIX
Device Catalogue NumberQC-7-30-HELIX
Device Lot NumberB149555
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2021
Date Device Manufactured01/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient SexFemale
-
-